The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 395-404

  Akbarian, Fatemehsadat ^a   Bajoghli, Hafez ^b,c   Haghighi, Mohammad ^d   Kalak, Nadeem ^e   Holsboer Trachsler, Edith ^e   Brand, Serge ^e,f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAHIDOL UNIVERSITY   (Thailand)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Anxiety; Autobiographical memory; Depression; PTSD

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ANXIETY; ARTICLE; AUTOBIOGRAPHICAL MEMORY; BECK ANXIETY INVENTORY; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; IMPACT OF EVENTS SCALE; INTERVIEW; MALE; POSTTRAUMATIC STRESS DISORDER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 84923194646     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S79581     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: American Psychiatric Association; 1994.
2. Health and human rights [webpage on Internet]. Post traumatic stress disorder. 2014. Available from: http://www.hhri.org/thematic/ptsd.html.
3. Difede J, Olden M, Cukor J. Evidence-based treatment of post-traumatic stress disorder. Annu Rev Med. 2014;65:319-332.
4. van Liempt S, Vermetten E, Geuze E, Westenberg HG. Pharmacotherapy for disordered sleep in post-traumatic stress disorder: A systematic review. Int Clin Psychopharmacol. 2006;21:193-202.
5. Schoenfeld FB, Deviva JC, Manber R. Treatment of sleep disturbances in posttraumatic stress disorder: A review. J Rehabil Res Dev. 2012;49:729-752.
6. Gradus JL, Qin P, Lincoln AK, et al. Posttraumatic stress disorder and completed suicide. Am J Epidemiol. 2010;171:721-727.
7. Sjöström N, Hetta J, Waern M. Persistent nightmares are associated with repeat suicide attempt: A prospective study. Psychiatry Res. 2009;170:208-211.
8. Tanskanen A, Tuomilehto J, Viinamäki H, Vartiainen E, Lehtonen J, Puska P. Nightmares as predictors of suicide. Sleep. 2001;24:844-847.
9. Ravindran LN, Stein MB. Pharmacotherapy of post-traumatic stress disorder. Curr Top Behav Neurosci. 2010;2:505-525.
10. Polak AR, Witteveen AB, Visser RS, et al. Comparison of the effectiveness of trauma-focused cognitive behavioral therapy and paroxetine treatment in PTSD patients: Design of a randomized controlled trial. BMC Psychiatry. 2012;12:166.
11. Brewin CR. Episodic memory, perceptual memory, and their interaction: Foundations for a theory of posttraumatic stress disorder. Psychol Bull. 2014;140:69-97.
12. Hendriksen H, Olivier B, Oosting RS. From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets. Eur J Pharmacol. 2014;732:139-158.
13. Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S. Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis. Br J Psychiatry. 2007;190:97-104.
14. Ipser J, Seedat S, Stein DJ. Pharmacotherapy for post-traumatic stress disorder - a systematic review and meta-analysis. S Afr Med J. 2006;96:1088-1096.
15. Steckler T, Risbrough V. Pharmacological treatment of PTSD - established and new approaches. Neuropharmacology. 2012;62(2):617-627.
16. Mellman TA, Clark RE, Peacock WJ. Prescribing patterns for patients with posttraumatic stress disorder. Psychiatr Serv. 2003;54(12):1618-1621.
17. Hetrick SE, Purcell R, Garner B, Parslow R. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010;(7):CD007316.
18. Otto MW, Hinton D, Korbly NB, et al. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: A pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003;41(11):1271-1276.
19. Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: A randomized controlled trial. Am J Psychiatry. 2012;169(1):80-88.
20. Sutherland K, Bryant RA. Autobiographical memory and the self-memory system in posttraumatic stress disorder. J Anxiety Disord. 2008;22(3):555-560.
21. Brown AD, Addis DR, Romano TA, et al. Episodic and semantic components of autobiographical memories and imagined future events in post-traumatic stress disorder. Memory. 2014;22(6):595-604.
22. Brown AD, Root JC, Romano TA, Chang LJ, Bryant RA, Hirst W. Overgeneralized autobiographical memory and future thinking in combat veterans with posttraumatic stress disorder. J Behav Ther Exp Psychiatry. 2013;44(1):129-134.
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.
24. Weiss DS, Marmar CR. The Impact of Event Scale - Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. 1st ed. New York City: Guilford Press; 1997. p. 399-411.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
26. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893-897.
27. Kopelman MD, Wilson BA, Baddeley AD. The autobiographical memory interview: A new assessment of autobiographical and personal semantic memory in amnesic patients. J Clin Exp Neuropsychol. 1989;11(5):724-744.
28. Clark DA, Beck AT. 2011. Cognitive therapy of anxiety disorders: Science and practice. New York: Guilford Press; 2011.
29. Southwick SM, Krystal JH, Morgan CA, et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry. 1993;50:266-274.
30. Schnurr PP, Friedman MJ, Bernardy NC. Research on posttraumatic stress disorder: epidemiology, pathophysiology, and assessment. J Clin Psychol. 2002;58:877-889.
31. Daly CM, Doyle ME, Radkind M, Raskind E, Daniels C. Clinical case series: The use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Mil Med. 2005;170:513-515.
32. van Mill JG, Hoogendijk WJ, Vogelzangs N, van Dyck R, Penninx BW. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010;71(3):239-246.
33. van Mill JG, Vogelzangs N, van Someren EJ, Hoogendijk WJ, Penninx BW. Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders. J Clin Psychiatry. 2014;75(2):119-126.
34. Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: Exploration of the direction of risk. J Psychiatr Res. 2006;40(8):700-708.
35. Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014;69(4):235-242.
36. Yehuda R, Bierer LM, Sarapas C, Makotkine I, Andrew R, Seckl JR. Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology. 2009;34(9):1304-1313.
37. Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015;51:589-597.